Month: January 2023

Jan 11 2023

Uncategorized

Cerevance Announces Positive Topline Data from Phase 1 Clinical Trial of CVN766 for the Potential Use in the Treatment of Schizophrenia

by Clinical Editor

No Comments

CVN766 was well tolerated with no serious adverse events CVN766, which has >1000-fold selectivity for the orexin 1 receptor, was well tolerated and showed no evidence of somnolence Data supports...

Jan 10 2023

Uncategorized

Brain Aging in People With Schizophrenia – Neuroscience News

by Clinical Editor

No Comments

Brain Aging in People With Schizophrenia  Neuroscience News

Jan 10 2023

Uncategorized

Brain Aging in People With Schizophrenia

by Clinical Editor

No Comments

Advanced brain aging may explain why, on average, people with schizophrenia have a significantly reduced life span.

Jan 10 2023

Uncategorized

Understanding the symptoms of schizophrenia

by Clinical Editor

No Comments

The symptoms of schizophrenia usually appear in late adolescence or early adulthood. They affect a person’s speech, thinking, emotions as well as social interactions and other everyday activities.

Jan 10 2023

Uncategorized

Cerevance Announces Positive Topline Data from Phase 1 Clinical Trial of CVN766 for the Potential Use in the Treatment of Schizophrenia

by Clinical Editor

No Comments

CVN766 was well tolerated with no serious adverse events CVN766, which has >1000-fold selectivity for the orexin 1 receptor, was well tolerated and showed no evidence of somnolence Data supports...

Jan 10 2023

Uncategorized

Schizophrenia Over the Holidays

by Clinical Editor

No Comments

However, due to the insidious onset of schizophrenia in my college years, I remember painful times struggling with severe psychosis. Mental illness presents challenges different from other illnesses …

Jan 10 2023

Uncategorized

Public Stigma Toward Schizophrenia Within Latino Communities in the United States.

by Clinical Editor

No Comments

Public stigma toward those experiencing symptoms of schizophrenia in the general population is high; yet research into such stigma within the diverse Latino communities remains under-investigated.

Jan 09 2023

Uncategorized

Promising 6-Month Interim Results Reported for Treatment-Resistant … – Psychiatric Times

by Clinical Editor

No Comments

Promising 6-Month Interim Results Reported for Treatment-Resistant …  Psychiatric Times

Jan 09 2023

Uncategorized

Experimental Add-On Drug Achieves “Striking” Results in Treatment … – Inside Precision Medicine

by Clinical Editor

No Comments

Experimental Add-On Drug Achieves “Striking” Results in Treatment …  Inside Precision Medicine

Jan 09 2023

Uncategorized

Public Stigma Toward Schizophrenia Within Latino Communities in the United States.

by Clinical Editor

No Comments

Public stigma toward those experiencing symptoms of schizophrenia in the general population is high; yet research into such stigma within the diverse Latino communities remains under-investigated.